866-997-4948(US-Canada Toll Free)

Curetis AG - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 33 Pages


Curetis AG (Curetis) is a molecular diagnostics company. It develops, manufactures and commercializes molecular diagnostics solutions for molecular disease testing. The company combines medical technology, molecular biology, diagnostics expertise and system engineering to automate molecular testing. The products offered by the company include Unyvero Solution, it targets severe bacterial infections as first disease area; Unyvero Solution Components such as Unyvero L4 Lysato, Unyvero A50 Analyzer, Unyvero C8 Cockpit and Unyvero Server Software; Unyvero Solution Configurations; Unyvero Cartridge Technology and Unyvero Cartridge Pipeline. Curetis is headquartered in Holzgerlingen, Germany.

This report is a source for data, analysis and actionable intelligence on the Curetis AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Key Facts 5
Curetis AG - Major Products and Services 6
Curetis AG Pipeline Products by Equipment Type 7
Curetis AG Pipeline Products by Development Stage 9
Curetis AG Pipeline Products by Therapy Area 11
Curetis AG Pipeline Products by Trial Phase 13
Curetis AG Pipeline Products by Milestone Summary 15
Blood Stream Infection Cartridge 17
Blood Stream Infection Cartridge Product Status 17
Blood Stream Infection Cartridge Product Description 17
Surgical Site Infection Cartridge 18
Surgical Site Infection Cartridge Product Status 18
Surgical Site Infection Cartridge Product Description 18
Tuberculosis Cartridge 19
Tuberculosis Cartridge Product Status 19
Tuberculosis Cartridge Product Description 19
Unyvero Analyzer 20
Unyvero Analyzer Product Status 20
Unyvero Analyzer Product Description 20
Unyvero Analyzer Product Milestone 20
Unyvero Analyzer Clinical Trial 21
Unyvero Implant & Tissue Infections Cartridge 24
Unyvero Implant & Tissue Infections Cartridge Product Status 24
Unyvero Implant & Tissue Infections Cartridge Product Description 24
Unyvero P50 Pneumonia Cartridge 25
Unyvero P50 Pneumonia Cartridge Product Status 25
Unyvero P50 Pneumonia Cartridge Product Description 25
Unyvero P50 Pneumonia Cartridge Product Milestone 25
Unyvero P50 Pneumonia Cartridge Clinical Trial 26
Curetis AG - Key Competitors 28
Curetis AG - Key Employees 29
Curetis AG - Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Curetis AG, Recent Developments 31
Jul 18, 2012: Curetis Signs Distribution Agreement With ATC For Unyvero Solution In Middle East 31
May 14, 2012: Curetis Receives CE Mark For Unyvero Solution And Initiates Commercialization 31
Oct 18, 2011: Curetis Opens Unyvero Cartridge Production Facility 32

Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Table


Curetis AG, Key Facts 1
Curetis AG Key Pipeline Products by Equipment Type 1
Curetis AG Key Pipeline Products by Therapy Area 1
Curetis AG Key Pipeline Products by Development Stage 1
Curetis AG Key Pipeline Products by Trial Phase 1
Curetis AG, Key Facts 5
Curetis AG, Major Products and Services 6
Curetis AG Number of Pipeline Products by Equipment Type 7
Curetis AG Pipeline Products by Equipment Type 8
Curetis AG Number of Pipeline Products by Development Stage 9
Curetis AG Pipeline Products by Development Stage 10
Curetis AG Number of Pipeline Products by Therapy Area 11
Curetis AG Pipeline Products by Therapy Area 12
Curetis AG Number of Pipeline Products by Trial Phase 13
Curetis AG Pipeline Products by Trial Phase 14
Curetis AG Number of Pipeline Products By Milestone Summary 15
Curetis AG Pipeline Products by Milestone Summary 16
Blood Stream Infection Cartridge - Product Status 17
Blood Stream Infection Cartridge - Product Description 17
Surgical Site Infection Cartridge - Product Status 18
Surgical Site Infection Cartridge - Product Description 18
Tuberculosis Cartridge - Product Status 19
Tuberculosis Cartridge - Product Description 19
Unyvero Analyzer - Product Status 20
Unyvero Analyzer - Product Description 20
Unyvero Analyzer - Product Milestone 20
Unyvero Analyzer - Evaluation of Unyvero System and the Unyvero P50 Pneumonia Cartridge- A Prospective, Multi-Center Trial 21
Unyvero Analyzer - Evaluation of Unyvero System in lower respiratory 22
tract Infection - A Prospective, Multi-Center Trial 22
Unyvero Implant & Tissue Infections Cartridge - Product Status 24
Unyvero Implant & Tissue Infections Cartridge - Product Description 24
Unyvero P50 Pneumonia Cartridge - Product Status 25
Unyvero P50 Pneumonia Cartridge - Product Description 25
Unyvero P50 Pneumonia Cartridge - Product Milestone 25
Unyvero P50 Pneumonia Cartridge - Evaluation of Unyvero System and the Unyvero P50 Pneumonia Cartridge- A Prospective, Multi-Center Trial 26
Curetis AG, Key Employees 29

List of Chart


Curetis AG Key Pipeline Products by Equipment Type 1
Curetis AG Pipeline Products by Equipment Type 7
Curetis AG Pipeline Products by Development Stage 9
Curetis AG Pipeline Products by Therapy Area 11
Curetis AG Pipeline Products by Trial Phase 13
Curetis AG Pipeline Products by Milestone Summary 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *